High resolution ultrasound including Elastography and Contrast-Enhanced Ultrasound (CEUS) for early detection and characterization of liver lesions in the humanized tumor mouse model

Clinical Hemorheology and Microcirculation

Volumn 52, Issue 2-4, 2012, Pages 93-106

  Wege, A K ^a   Schardt, K ^a   Schaefer, S ^b   Kroemer, A ^b   Brockhoff, G ^a   Jung, E M ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

breast cancer; contrast enhanced ultrasound (CEUS); elastography; Humanized tumor mice (HTM); liver tumors; microcirculation

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CD79A ANTIGEN; SONOVUE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B SCAN; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER TRANSPLANTATION; CAPILLARY FLOW; CONTRAST ENHANCED ULTRASOUND; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG UPTAKE; EARLY DIAGNOSIS; ECHOGRAPHY; ELASTOGRAPHY; GRANULOMATOUS HEPATITIS; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER GRANULOMA; LIVER TUMOR; MICROCIRCULATION; MOUSE; NEWBORN; NONHUMAN; TUMOR DIFFERENTIATION;

ANIMALS; ANTIGENS, CD34; BREAST NEOPLASMS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC CELLS, CIRCULATING; TRANSPLANTATION CHIMERA;

EID: 84868611640     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1587     Document Type: Article

References (33)

1. T. Albrecht, M.J. Blomley, P.N. Burns, S. Wilson, C.J. Harvey, E. Leen, M. Claudon, F. Calliada, J.M. Correas, M. LaFortune, R. Campani, C.W. Hoffmann, D.O. Cosgrove and F. LeFevre, Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study, Radiology 227 (2003), 361-370. (Pubitemid 36514748)
2. S. Canale, C. Cocco, C. Frasson, E. Seganfreddo, E. Di Carlo, E. Ognio, C. Sorrentino, D. Ribatti, A. Zorzoli, G. Basso, C. Dufour and I. Airoldi, Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model, Leukemia 25 (2011), 1815-1824.
3. P.W. Denton, J.D. Estes, Z. Sun, F.A. Othieno, B.L. Wei, A.K. Wege, D.A. Powell, D. Payne, A.T. Haase and J.V. Garcia, Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice, PLoS Med 5 (2008), e16.
4. C.F. Dietrich, W. Kratzer, D. Strobe, E. Danse, R. Fessl, A. Bunk, U. Vossas, K. Hauenstein, W. Koch, W. Blank, M. Oudkerk, D. Hahn and C. Greis, Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI, World J Gastroenterol 12 (2006), 1699-1705.
5. T.P. Gauthier, M.A. Averkiou and E.L. Leen, Perfusion quantification using dynamic contrast-enhanced ultrasound: The impact of dynamic range and gain on time-intensity curves, Ultrasonics 51 (2011), 102-116.
6. C. Greis, Ultrasound contrast agents as m11arkers of vascularity and microcirculation, Clin Hemorheol Microcirc 43 (2009), 1-9.
7. C. Greis, Quantitative evaluation of microvascular blood flow by contrast-enhanced ultrasound (CEUS), Clin Hemorheol Microcirc 49 (2011), 137-149.
8. A. Helck, M. D'Anastasi, M. Notohamiprodjo, S. Thieme,W. Sommer,M. Reiser and D.A. Clevert, Multimodality imaging using ultrasound image fusion in renal lesions, Clin Hemorheol Microcirc 50 (2012), 79-89.
9. T. Isozaki, K. Numata, T. Kiba, K. Hara, M. Morimoto, T. Sakaguchi, H. Sekihara, T. Kubota, H. Shimada, T. Morizane and K. Tanaka, Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US, Radiology 229 (2003), 798-805. (Pubitemid 37467586)
10. H.J. Jang, T.K. Kim, P.N. Burns and S.R.Wilson, Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: Comparison with histologic differentiation, Radiology 244 (2007), 898-906. (Pubitemid 47292103)
11. E.M. Jung, R. Kubale, K.P. Jungius, W. Jung, M. Lenhart and D.A. Clevert, Vascularization of liver tumors-preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison), Clin Hemorheol Microcirc 34 (2006), 483-497.
12. E.M. Jung, K.P. Jungius, N. Rupp, M. Gallegos, G. Ritter, M. Lenhart, D.A. Clevert and R. Kabale, Contrast enhanced harmonic ultrasound for differentiating breast tumors-first results, Clin Hemorheol Microcirc 33 (2005), 109-112.
13. E.M. Jung, D.A. Clevert, A.G. Schreyer, S. Schmitt, J. Rennert, R. Kubale, S. Feuerbach and F. Jung, Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study, World J Gastroenterol 13 (2007), 6356-6364.
14. E.M. Jung,W. Uller, C. Stroszczynski and C.A. Clevert, Contrast-enhanced sonography. Therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma, Radiologe 51(6) (2011), 462-468.
15. E. Leen, W.J. Angerson, S. Yarmenitis, G. Bongartz, M. Blomley, A. Del Maschio, V. Summaria, G. Maresca, C. Pezzoli and J.B. Llull, Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions, Eur J Radiol 41(3) (2002), 200-206. (Pubitemid 34171562)
16. E. Leen, P. Ceccotti, C. Kalogeropoulou,W.J. Angerson, S.J.Mougand P.G. Horgan, Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography, AJR Am J Roentgenol 186(6) (2006), 1551-1559. (Pubitemid 46112517)
17. E. Leen, P. Ceccotti, S.J. Moug, P. Glen, J. MacQuarrie, W.J. Angerson, T. Albrecht, J. Hohmann, A. Oldenburg, J.P. Ritz and P.G. Horgan, Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: An essential investigation before resection? Ann Surg 243 (2006), 236-240. (Pubitemid 43185443)
18. M. Loss, J. Schneider, W. Uller, P. Wiggermann, M.N. Scherer, W. Jung, H.H. Schlitt, C. Stroszczynski and E.M. Jung, Intraoperative high resolution linear contrast enhanced ultrasound (IOUS) for detection of microvasculariza tion of malignant liver lesions before surgery or radiofrequeny ablation, Clin Hemorheol Microcirc 50(1) (2012), 65-77.
19. M.W. Melkus, J.D. Estes, A. Padgett-Thomas, J. Gatlin, P.W. Denton, F.A. Othieno, A.K. Wege, A.T. Haase and J.V. Garcia, Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1, Nat Med 12(11) (2006), 1316-1322. (Pubitemid 44706935)
20. A. Oldenburg and T. Albrecht, Baseline and Contrast-enhanced ultrasound of the liver in tumor patients, Ultraschall Med 29(5) (2008), 488-498.
21. P.M. Paprottka, P. Zengel, M. Ingrisch, C.C. Cyran, M. Eichhorn, M.F. Reiser, K. Nikolaou and D.A. Clevert, Contrastenhanced ultrasound in animal models, Radiologe 51(6) (2011), 506-513.
22. E. Quaia, F. Calliada, M. Bertolotto, S. Rossi, L. Garioni, L. Rosa and R. Pozzi-Mucelli, Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: Diagnostic performance and confidence, Radiology 232(2) (2004), 420-430. (Pubitemid 38971282)
23. V. Salvatore, A. Borghi and F. Piscaglia, Contrast-enhanced ultrasound for liver imaging: Recent advances, Curr Pharm Des 18(15) (2012), 2236-2252.
24. M. Schneider, M. Arditi, M.B. Barrau, J. Brochot, A. Broillet, R. Ventrone and F. Yan, BR1: A new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles, Invest Radiol 30(8) (1995), 451-457.
25. K. Seitz, C. Greis, A. Schuler, T. Bernatik,W. Blank, C.F. Dietrich and D. Strobel, Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study, Ultraschall Med 32(6) (2011), 598-603.
26. L.D. Shultz, F. Ishikawa and D.L. Greiner, Humanized mice in translational biomedical research, Nat Rev Immunol 7(2) (2007), 118-130. (Pubitemid 46174859)
27. D. Strobel, T. Bernatik, W. Blank, A. Schuler, C. Greis, C.F. Dietrich and L. Seitz, Diagnostic accuracy of CEUS in the differential diagnosis of small (≤20 mm) and subcentimetric (≤10 mm) focal liver lesions in comparison with histology, Results of the DEGUM multicenter trial, Ultraschall Med 32(6) (2011), 593-597.
28. T. Strowig, C. Gurer, A. Ploss, Y.F. Liu, F. Arrey, J. Sashihara, G. Koo, C.M. Rice, J.W. Young, A. Chadburn, J.I. Cohen and C. Münz, Priming of protective T cell responses against virus-induced tumors in mice with human immune system components, J Exp Med 206(6) (2009), 1423-1434.
29. Z. Sun, P.W. Denton, J.D. Estes, F.A. Othieno, B.L. Wei, A.K. Wege, M.W. Melkus, A. Padgett-Thomas, M. Zupancic, A.T. Haase and J.V. Garcia, Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1, J Exp Med 204(4) (2004), 705-714.
30. A.K. Wege, W. Ernst, J. Eckl, B. Frankenberger, A. Vollmann-Zwerenz, D.N. Männel, O. Ortmann, A. Kroemer and G. Brockhoff, Humanized tumor mice-A newmodel to study and manipulate the immune response in advanced cancer therapy, Int J Cancer (2011), doi: 10.1002/ijc.26159.
31. S.R. Wilson and P.N. Burns, An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography, Am J Roentgenol 186(5) (2006), 1401-1412. (Pubitemid 46115735)
32. S.R. Wilson and P.N. Burns, Microbubble-enhanced US in body imaging: What role? Radiology 257(1) (2012), 24-39.
33. S.R. Wilson, L.D. Greenbaum and B.B. Goldberg, Contrast-enhanced ultrasound: What is the evidence and what are the obstacles? Am J Roentgenol 193(1) (2009), 55-60.